March 7, 2017 / 11:06 AM / 5 months ago

BRIEF-Juniper Pharmaceuticals Q4 EPS $0.88

March 7 (Reuters) - Juniper Pharmaceuticals Inc

* Juniper pharmaceuticals reports fourth quarter and full-year 2016 financial and operating results

* Q4 earnings per share $0.88

* Q4 revenue rose 143 percent to $20.9 million

* Juniper pharmaceuticals inc - expect to continue ind-enabling activities which could potentially support three ind filings in first half of 2018

* Juniper pharmaceuticals inc- "operating expense will increase modestly year over year" in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below